Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

Am J Hematol. 2019 May;94(5):E141-E143. doi: 10.1002/ajh.25440. Epub 2019 Feb 27.

Authors

M Hasib Sidiqi¹, Surendra Dasari², Ellen D McPhail³, Francis K Buadi¹, Rahma Warsame¹, Martha Q Lacy¹, David Dingli¹, Wilson I Gonsalves¹, Prashant Kapoor¹, Taxiarchis Kourelis¹, Nelson Leung^{1

4}, Eli Muchtar¹, Martha Grogan⁵, John A Lust¹, Shaji Kumar¹, Robert A Kyle¹, Vincent S Rajkumar¹, Morie Gertz¹, Angela Dispenzieri¹

Affiliations

¹ Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota.
² Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, Minnesota.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota.
⁴ Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, Minnesota.
⁵ Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, Minnesota.

PMID: 30773682
DOI: 10.1002/ajh.25440

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Biopsy
Female
Humans
Immunoglobulin Light-chain Amyloidosis* / diagnosis
Immunoglobulin Light-chain Amyloidosis* / pathology
Male
Middle Aged
Monoclonal Gammopathy of Undetermined Significance* / diagnosis
Monoclonal Gammopathy of Undetermined Significance* / pathology
Retrospective Studies